[1] |
GAO Lili, WANG Yuzhu, WANG Yan, LI Jian, WANG Jun.
General considerations for clinical pharmacology of antitumor antibody-conjugated drugs: Implications from FDA review cases
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(1): 75-85.
|
[2] |
JIANG Yuhua, ZHI Hui, LU Linming, TIAN Dahao, WANG Xiaoqing, GE Yu, XIE Shangfu, WANG Qi.
AHVAC-I reverses tumor growth of cancer-associated fibroblasats in gastric cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(4): 389-394.
|
[3] |
XING Han, NING Chen, KONG Dexuan, CAI Hui, ZHOU Shiyu, REN Chang, KONG Ying, CHENG Yujie, CHEN Xijing.
Tissue distribution and excretion study of GL-V9 in rats, a wogonin derivative with significant antitumor activity
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(8): 889-895.
|
[4] |
LI Hongli, WEN Dandan, ZHOU Meiliang, WANG Haihua, PENG Xixu, GAO Lichen.
Advances in extraction and mechanism of antitumor active components from Fagopyrum dibotrys
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(7): 833-840.
|
[5] |
GUO Li, HAN Chenyang.
Preparation of piperine liposomes and its antitumor activity of gastric cancer cells in vitro
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(11): 1240-1245.
|
[6] |
YAO Tianyi, YIN Shaoping, LIU Wen, ZHAO Yanlei, WANG Guangji, LI Juan.
Biodistribution and biological evaluation of paclitaxel polymer micelles
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(11): 1207-1214.
|
[7] |
SHANG Li-na, HONG Ming-yue.
Recent progresses on antibody-targeted conjugates of antitumor antibiotics
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(9): 1075-1080.
|
[8] |
YANG Jian, YANG Qian.
Advances in pharmacological research of 8-methoxypsoralen
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(10): 1177-1182.
|
[9] |
LI Li-hua, CHEN Kao-shan, YU Li-zhen, BU Xiao-yang.
Experimental study on anti-tumor activity of extracellular polysaccharides from Trichoderma pseudokoningii
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(3): 282-285.
|
[10] |
XU Wei-feng, WANG Feng, CHEN Hai-min, LU Xiao-ling, YAN Xiao-jun.
Preliminary study on antitumor effects of Fascaplysin and safety in vivo in transplanted S180 tumor of ICR mice
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(11): 1206-1210.
|
[11] |
HUA Zhi-hui,HOU Ying, SONG Hong-tao.
Advancement on pharmacogenomics of partial antitumor drugs
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(6): 701-706.
|
[12] |
WANG Xiao-ji, YANG Jing-ya, LIU Jian-wen.
Research progress of chitosan derivatives in antitumor studies
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2008, 13(8): 952-956.
|
[13] |
CHEN Xiao, WANG Zhe-yuan, ZHANG You-cheng, LI Wen-guang.
Anti-tumor and antioxidation effects of 4-p-amino-benzoinc acid-4’-demethylepipodophyllotoxin ester
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2008, 13(3): 288-292.
|
[14] |
NI Wu-hua, LUO Chao, YU Kang, WU Jian-bo.
Establishment of fusion protein eukaryotic expression vector of singlechain antibody fragments reacting with human CD13 and scorpion toxin polypeptide AGAP and the target lethal effect to NB4 cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2008, 13(11): 1231-1236.
|
[15] |
LI Ying-xin, LEI Dan-qing, ZHOU Xian-guo.
Experimental study of a new small peptide purifing from agkitrodon acutus venom on antitumor activities
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2007, 12(2): 187-190.
|